Immunotec Gets FDA Approval For Study On Protein Supplement

by louabbott on August 1, 2009

Williamsville, NY, USA – Published August 1, 2009

[link no longer available]

Immunotec Inc. (IMM.TO), said the US FDA has approved an investigator-held IND to conduct a pilot study of
forty-eight patients to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV non-small cell lung cancer or NSCLC.

Also, read our company overview:  Immunotec Facts, News and Review

Be Sociable, Share!

{ 0 comments… add one now }

Leave a Comment

Thoughtful and constructive comments that benefit network marketing professionals and the industry will be accepted and published after review.
We will not publish rude or insulting comments, plugs for your company or product, or generally non-helpful or self-promoting content.

Previous post:

Next post: